Research News
Women using Implanon needed for research trials
3 May 2005
Over 200 women using Implanon are needed to participate in research trials. Women must be aged between 18-45 years, have used Implanon for the past three months and have experienced irregular or prolonged bleeding .
Prince Henry’s Institute is part of an all Australian research consortium that has launched the second phase of a research study to help find a solution for a troublesome side effect of the popular sub dermal implant contraceptive, Implanon.
Implanon is a very effective long acting and easily reversible contraceptive. It is a matchstick sized implant that is inserted under the skin of the inner aspect of the arm. It administers a low dose of a progesterone type hormone, which effectively prevents ovulation for 3 years.
Approximately 25% of women who want to use Implanon have discontinued using it because they have experienced frequent or prolonged bleeding. The research team have discovered several treatments that are successful in stopping individual episodes of bleeding. Volunteers are needed to trial the effectiveness of these treatments and combinations of these treatments in regulating long-term bleeding.
The Institute’s role in this trial is to understand what happens at a molecular level in the human endometrium, with the use of the various treatments.
Women wanting to take part in the Implanon trial should contact Corry Garamszegi, Research Nurse, The Royal Women's Hospital - 0419 148 001 or the Women’s Health Information Centre - 03 9344 2007
For more information about the trial, visit ‘Services for Women’ on the RWH Well Women’s website - http://www.rwh.org.au/wellwomens
© Prince Henry's Institute of Medical Research Disclaimer | Links to other sites
ABN 77 601 754 678
|